This is further to our letter dated November 04, 2025, intimating the date of the Board Meeting for the approval of Un-audited (Standalone and Consolidated) Financial Results for the quarter ....

Revenue growth above 20%Profit growth above 25%Exceptional itemResults restatedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹156.00

prior close

₹156.05

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-0.3% vs market

Commodity Chemicals peers, median of 51sector+0.5%+0.2% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.2 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-2.5

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.9-0.3+0.5+0.2

Next day

+0.4+0.8-0.4-0.1+0.6

-5.8+0.7-6.6-0.4-5.4

-9.2+1.3-10.5-0.8-8.4

-11.4+0.5-11.9-1.9-9.5

-10.0+0.4-10.4-1.3-8.7

-13.1-1.5-11.7-1.6-11.6

15d

-22.4-2.4-20.0-3.7-18.8

-16.0-4.4-11.6-6.1-9.9

-20.2-7.2-13.0-9.7-10.5

-21.3-5.0-16.3-11.7-9.7

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 51Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board approved standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, with a clean limited review report from auditor S S Kothari Mehta & Co. LLP. Standalone revenue from operations jumped to Rs. 1,191.01 lakhs in Q2 FY26 from Rs. 388.57 lakhs in Q2 FY25 (around 3x), while H1 FY26 standalone revenue rose to Rs. 1,418.03 lakhs from Rs. 636.49 lakhs. Standalone profit after tax for H1 FY26 swung to Rs. 259.81 lakhs from a prior-year loss of Rs. 37,565.18 lakhs, which had been dragged down by a one-time Rs. 37,494.57 lakhs exceptional loss on the demerger of the chemicals business. Consolidated revenue was broadly flat at Rs. 5,085.02 lakhs for H1 FY26, with consolidated PAT of Rs. 489.17 lakhs (down from Rs. 936.50 lakhs).

Likely market impact

The company has effectively transitioned post the chemicals demerger, with its continuing businesses now being Investments & Trading and General Engineering Products (via subsidiary Duncan Engineering). Standalone numbers show a strong turnaround, but shareholders should note consolidated profits have moderated versus the prior period, and the clean auditor report means no red flags from the review.